Bank Of America Corp Imago Bio Sciences, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$15.03 - $35.96 $856,634 - $2.05 Million	56,995 Added 1220.19%	61,666 $2.22 Million
Q3 2022 Nov 14, 2022	SELL	$14.15 - $19.5 $54,902 - $75,660	-3,880 Reduced 45.37%	4,671 $71,000
Q2 2022 Aug 12, 2022	SELL	$11.81 - $20.92 $129,732 - $229,806	-10,985 Reduced 56.23%	8,551 $114,000
Q1 2022 May 16, 2022	BUY	$16.97 - $25.0 $227,296 - $334,850	13,394 Added 218.07%	19,536 $377,000
Q4 2021 Feb 08, 2022	BUY	$16.22 - $29.69 $85,771 - $157,000	5,288 Added 619.2%	6,142 $145,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $13,664 - $24,629	854 New	854 $18,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.